Announcements
- Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: Annual General Meeting completed
- Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
- Hofseth Biocare ASA: HBC ANNUAL REPORT 2023
- Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
- Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION
- Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN
- Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT
- Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity
- Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
More ▼
Key statistics
On Thursday, Hofseth Biocare ASA (HBQ:STU) closed at 0.1455, 17.81% above the 52 week low of 0.1235 set on May 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1385 |
---|---|
High | 0.1455 |
Low | 0.1385 |
Bid | 0.150 |
Offer | 0.222 |
Previous close | 0.1385 |
Average volume | 1.06k |
---|---|
Shares outstanding | 395.08m |
Free float | 165.07m |
P/E (TTM) | -- |
Market cap | 841.52m NOK |
EPS (TTM) | -0.2449 NOK |
Data delayed at least 15 minutes, as of May 23 2024.
More ▼